Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof

Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof

US Patent 11111297 · Granted Sep 7, 2021

Estimated economic value: $168,031,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025